Sunday Special: FDA greenlights drug to transform pancreatic cancer care

Welcome back, Superhuman. Pancreatic cancer has long been one of medicine’s toughest diagnoses. A newly approved pill is now helping some advanced patients live nearly twice as long as chemotherapy alone. Meanwhile, a dark horse startup is using drone technology to literally make it rain.

1. FDA greenlights drug to transform pancreatic cancer care: The FDA approved daraxonrasib, a twice-daily pill that can help advanced pancreatic cancer patients live a median of over 13 months, compared to less than 7 months on chemotherapy. It works by targeting KRAS, a mutated protein once thought impossible to drug. Pancreatic cancer kills over 50,000 Americans a year with brutal survival odds, so a treatment doubling life expectancy marks a genuine turning point for a disease long considered nearly hopeless.

2. MIT unveils new aircraft design for regional travel: MIT startup Electra has unveiled designs for a new hybrid aircraft, which uses eight electric motors and a gas-powered generator to take off and land in about the size of a soccer field. With a 1,200-mile range and 200 mph cruising speed, it's built for the 50- to 250-mile trips that are often too short to fly but too long to drive comfortably. The company just landed $850 million to scale production in Ohio, aiming to build 800 aircraft a year.

3. Startup claims to create 19 million gallons of rain on demand: Cloud-seeding startup Rainmaker flew drones over the Kenai Peninsula, releasing silver iodide into clouds to trigger rain and snow formation, then used radar analysis to estimate that the flight generated roughly 19 million gallons of rain in three hours. The figure comes from modeling, not direct measurement, and the company admits real uncertainty. It hopes to eventually apply the technique to drought-stressed regions like the Colorado River basin.

4. A new brain map could finally point toward autism treatments: Researchers at UCSF mapped 100 proteins linked to severe autism and traced more than 1,000 other proteins they interact with, revealing how mutations disrupt these partnerships. In one case, a mutation broke the bond between two proteins, letting one "go rogue" and interfere with normal brain cell division. The discovery gives scientists concrete new targets for drugs, something 20 years of gene research hadn't managed to deliver.

StackAI is how IT teams safely deploy AI agents across the entire enterprise.

Trusted by LifeMD, BAE Systems, Nubank + more.

Get your AI strategy today

1. Xteink X4: A tiny magnetic E Ink e-reader that snaps onto the back of your iPhone, letting you read distraction-free without apps, notifications, or social media.

2. FitBit Luffu Link: A screenless health band to help families keep track of aging parents, kids, partners, and loved ones without turning it into another fitness tracker.

3. Speedo iQ Vanquisher: Racing goggles with a tiny tracker built into the side to give swimmers stroke data after practice or competition, without wearing a watch or staring at a screen in the pool.

4. Ninja HydraSense: An intelligent water filtration system built to clean tap water faster, track filter life automatically, and keep the minerals that make water taste good.

💰 Lost Fortune: Imagine knowing you’re a millionaire but being unable to touch the money. One man spent 12 years locked out of his Bitcoin wallet — until he finally found a way back in.

🧠 Mind Canvas: Neuralink is showing what brain-computer interfaces can look like beyond the lab. Audrey is now creating digital art using nothing but her thoughts.

📱 Drop Test: An iPhone was dropped from 100,000 feet above the Earth, fell for 25 minutes, and endured temperatures of -60°C. It landed without a scratch — and one piece of gear apparently deserves the credit.

✋ Hand Signal: Huawei’s latest phone quietly solves one of big-screen smartphones’ most annoying problems. Its UI rearranges itself depending on whether you’re holding it in your left or right hand.

⚡ Power Play: The fight over America’s AI infrastructure may have had some very artificial participants. X says it’s uncovered hundreds of accounts tied to a massive Chinese bot network, pushing narratives around data centers and power.

Anyone can prompt a chatbot. Applying ML, predictive analytics, and gen AI to real business decisions is a different skill. 

The AI for Business & Finance Certificate Program teaches applied AI frameworks through Columbia Exec Ed faculty + Wall Street Prep practitioners.

8 weeks, online. Code SUPERHUMAN saves $300. Starts Nov 9.

Get the syllabus →

Fat Cut: In a UCL trial of 35 patients, an experimental gene therapy called VERVE-102 permanently switched off a liver gene, letting the body clear more "bad" LDL cholesterol from the blood. At the highest dose, LDL dropped 62% and stayed low for up to a year without the need for any daily pill. About half of statin users quit their medication within a year, so a one-time fix could be a major win for heart health.

Crash Cure: Scientists have analyzed harsh braking and swerving data from 700,000 vehicles across Australia and found that near-miss hotspots strongly overlap with known accident black spots, but many risky areas aren't yet flagged by authorities at all. With near misses in Australia climbing toward 200,000 a year, the idea is to intervene with lower speed limits or better infrastructure before crashes happen.

Pain Switch: In a new study, scientists have found that a brain region called the locus coeruleus can flip from suppressing pain to actively fueling it after nerve injury. In mice, removing specific opioid receptors from this region made pain worse, while restoring them reversed it. This could have significant implications: creating painkillers to target this single brain circuit could offer relief from chronic nerve pain without addiction risks.

You’re the reason our team spends hundreds of hours every week researching and writing this email. Please let us know what you thought of today’s email to help us create better emails for you.

Until next time,

Zain, Faiq, and the Superhuman AI team